Three Ways Mobile Research Nursing is Transforming the Clinical Trial Experience Following the emergence of the novel coronavirus, more than 1000 clinical trials for non-COVID-19 indications were delayed, put on hold, or even postponed outright. In a Medidata survey conducted in April 2020, nearly 70% of investigative site personnel indicated […]
In the Media
Has COVID-19 transformed the future of rare disease research?
Figures published in Tufts CSDD Impact Reports in 20201 highlight the passion within the rare disease population to be involved in research, with dropout rates lower than in any other indication. Recruitment rates were higher across all indications than in previous years. The average dropout rate of 19.1 per cent […]
The Human CEO Podcast, Helen Springford
The Human CEO Podcast, Helen Springford PodBean, January 2021 Focusing on approach to leadership, challenges faced and how to overcome them, also asking what it takes to be a good leader. “I get a lot of very positive feedback from my emails that I send out saying they really appreciate […]
Experience with Mobile Research Nursing (PM360, Dec20)
In a Medidata survey conducted in April 2020, nearly 70% of investigative site personnel indicated that COVID-19 affected their ability to conduct ongoing studies and 78% believed that the pandemic impacted their ability to initiate new trials.2 And yet, according to a report released by Greenphire in October 2020, patient […]
Colours of Change (International Clinical Trials Magazine, Dec20)
Some time ago, a survey was conducted on clinical trial professionals to determine what concerns worried the industry most. Experts were consulted from far and wide within pharmaceutical company sponsors, contract research organisations, site representatives and vendors. Despite all the great work by these collective groups, an overwhelming number of studies fail for the simple reason, that not […]
This time its personal (Rare Revolution, October 20)
This originally appeared in RARE Revolution Magazine Issue No. 17 By Jessica Zeigler, Head of US Proposals When Jessica took a break from her career to devote her time to supporting her daughter Amelia, who has NOD2-associated autoinflammatory disease, she never expected that her unique insight into rare disease would […]
Pandemic spotlights the rise of mobile research nursing (Pharmaceutical Commerce, August 2020)
The impact of the COVID-19 pandemic on clinical trials has been well chronicled in recent months, with new and ongoing studies targeting a number of diseases, particularly chronic conditions, being hit hard by reductions in patient participation. This has shifted fundamental approaches in clinical operations, with some pharma sponsors turning to digital […]
Latest News on Outsourcing-Pharma.com
- Aptar and Fluidda partner to ease inhaled drug regulatory pathway 29 September 2022The two companies have agreed an exclusive collaboration that will see Aptarâs SmartTrack testing service be complemented by Fluiddaâs functional respiratory imaging technology.